Selective estrogen receptor-β ligands
The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Barlaam, Bernard Dantzman, Cathy |
| description | The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07256201</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07256201</sourcerecordid><originalsourceid>FETCH-uspatents_grants_072562013</originalsourceid><addsrcrecordid>eNrjZFALTs1JTS7JLEtVSC0uKcpPT81TKEpNTi0oyS_SPbdJISczPTEvpZiHgTUtMac4lRdKczMouLmGOHvolhYXJJak5pUUx6cXJYIoA3MjUzMjA0NjIpQAAKWLKUc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Selective estrogen receptor-β ligands</title><source>USPTO Issued Patents</source><creator>Barlaam, Bernard ; Dantzman, Cathy</creator><creatorcontrib>Barlaam, Bernard ; Dantzman, Cathy ; AstraZeneca AB</creatorcontrib><description>The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer.</description><language>eng</language><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7256201$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7256201$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Barlaam, Bernard</creatorcontrib><creatorcontrib>Dantzman, Cathy</creatorcontrib><creatorcontrib>AstraZeneca AB</creatorcontrib><title>Selective estrogen receptor-β ligands</title><description>The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZFALTs1JTS7JLEtVSC0uKcpPT81TKEpNTi0oyS_SPbdJISczPTEvpZiHgTUtMac4lRdKczMouLmGOHvolhYXJJak5pUUx6cXJYIoA3MjUzMjA0NjIpQAAKWLKUc</recordid><startdate>20070814</startdate><enddate>20070814</enddate><creator>Barlaam, Bernard</creator><creator>Dantzman, Cathy</creator><scope>EFH</scope></search><sort><creationdate>20070814</creationdate><title>Selective estrogen receptor-β ligands</title><author>Barlaam, Bernard ; Dantzman, Cathy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_072562013</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Barlaam, Bernard</creatorcontrib><creatorcontrib>Dantzman, Cathy</creatorcontrib><creatorcontrib>AstraZeneca AB</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Barlaam, Bernard</au><au>Dantzman, Cathy</au><aucorp>AstraZeneca AB</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Selective estrogen receptor-β ligands</title><date>2007-08-14</date><risdate>2007</risdate><abstract>The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07256201 |
| source | USPTO Issued Patents |
| title | Selective estrogen receptor-β ligands |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T16%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Barlaam,%20Bernard&rft.aucorp=AstraZeneca%20AB&rft.date=2007-08-14&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07256201%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |